REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,311 | +13.0% | 64,347 | -1.0% | 0.00% | – |
| Q2 2023 | $687,890 | -9.2% | 65,018 | -15.6% | 0.00% | – |
| Q1 2023 | $757,788 | -20.1% | 77,011 | +19.5% | 0.00% | – |
| Q4 2022 | $947,972 | +58.5% | 64,444 | +30.7% | 0.00% | – |
| Q3 2022 | $598,000 | -14.6% | 49,310 | -1.5% | 0.00% | – |
| Q2 2022 | $700,000 | +17.8% | 50,075 | +20.0% | 0.00% | – |
| Q1 2022 | $594,000 | -9.5% | 41,745 | +34.2% | 0.00% | – |
| Q4 2021 | $656,000 | -37.8% | 31,096 | -22.6% | 0.00% | – |
| Q3 2021 | $1,054,000 | -49.3% | 40,157 | -39.7% | 0.00% | – |
| Q2 2021 | $2,077,000 | +24.4% | 66,618 | +22.5% | 0.00% | – |
| Q1 2021 | $1,669,000 | +172.3% | 54,370 | +204.0% | 0.00% | – |
| Q4 2020 | $613,000 | +60.1% | 17,883 | +44.8% | 0.00% | – |
| Q2 2020 | $383,000 | – | 12,353 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |